In Brief: Perclose Inc.
This article was originally published in The Gray Sheet
Executive Summary
Perclose Inc.: Launches in Europe, Canada and Japan its second-generation two-suture Prostar Plus 10F percutaneous vascular surgical system for use in closing arterial access sites following catheterization procedures. The firm also announces completion of initial U.S. clinical trials of the system. Perclose has filed for an investigational device exemption to incorporate the device into its randomized, 500-patient STAND II clinical trial, which is comparing use of the firm's Prostar Plus 8F to standard compression ("The Gray Sheet" May 20, In Brief)...